- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Aetna Leaves ACA Markets; Home Care in Medicaid; CBO Score of AHCA Coming
Aetna Will Leave the ACA Marketplace in 2018
In 2018, Aetna was only slated to provide coverage in Delaware and Nebraska, but the company has now decided to completely exit the Affordable Care Act (ACA) exchanges. According to FOX Business, Aetna was still projected to lose more than $200 million in 2017, despite only participating in 4 states. In 2016, the insurer had sold plans in 15 states. HHS Secretary Tom Price, MD, pointed to the move as proof that the ACA markets are still unstable.
States Get Extra Time for Medicaid Home Services
CMS has granted states an additional 3 years to states to carry out plans to deliver care to Medicaid enrollees in the home and community, rather than in the nursing home. The Obama administration had set federal standards in 2014 to improve the care disabled and elderly Americans receive outside of institutions, according to Kaiser Health News. States had fought the rule, as had nursing homes and for-profit group homes. The delay received support from the National Association of Medicaid Directors.
CBO Expects an AHCA Score in 2 Weeks
The amended version of the American Health Care Act (AHCA) passed the House without an updated score from the Congressional Budget Office (CBO), but the same won’t be true in the Senate. Politico reported that since the Senate will pass the bill through the budget reconciliation process, the CBO score is required for the parliamentarian to review the legislation. The Senate version of AHCA will need to save at least as much money as the House bill. The CBO expects to release its analysis the week of May 22.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
